@prefix this: . @prefix sub: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-gda: . @prefix dgn-void: . sub:head { this: np:hasAssertion sub:assertion ; np:hasProvenance sub:provenance ; np:hasPublicationInfo sub:publicationInfo ; a np:Nanopublication . } sub:assertion { dgn-gda:DGN8e131865c56b5d8b3821b8f78fb43753 sio:SIO_000628 miriam-gene:302 , lld:C0027627 ; a sio:SIO_001123 . } sub:provenance { sub:assertion dcterms:description "[Serum ANXA2 expression in HCC patients was correlated with HBV infection (27.38 � 5.67 ng/mL vs 18.58 � 7.83 ng/mL, P < 0.01), extrahepatic metastasis (26.11 � 5.43 ng/mL vs 22.79 � 5.64 ng/mL, P < 0.01), and portal vein thrombus (26.03 � 5.99 ng/mL vs 23.06 � 5.03 ng/mL, P < 0.01), and was significantly higher (P < 0.01) in the moderately- (26.19 � 5.34 ng/mL) or the poorly- differentiated group (27.05 � 5.13 ng/mL) than in the well differentiated group (20.43 � 4.97 ng/mL), and in the tumor node metastasis stages III-IV (P < 0.01) than in stages?I-II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ; wi:evidence dgn-void:source_evidence_literature ; sio:SIO_000772 miriam-pubmed:23139605 ; prov:wasDerivedFrom dgn-void:BEFREE ; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:BEFREE pav:importedOn "2017-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212 ; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en ; rdfs:label "DisGeNET evidence - LITERATURE"@en . } sub:publicationInfo { this: dcterms:created "2017-10-17T13:10:28+02:00"^^xsd:dateTime ; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup ; dcterms:subject sio:SIO_000983 ; prv:usedData dgn-void:disgenetv3.0rdf ; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v5.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v5.0.0" . }